3rd Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2017)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: White House Office; Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Health care reform, Medicare, Medicaid, access to care

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

NIH, CDC, FDA and health care/public health appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.